Intrexon Corp (NYSE:XON) Institutional Investor Sentiment Trend

April 17, 2018 - By Henry Gaston

Intrexon Corporation (NYSE:XON) Logo

Sentiment for Intrexon Corp (NYSE:XON)

Intrexon Corp (NYSE:XON) institutional sentiment increased to 1.38 in Q4 2017. Its up 0.18, from 1.2 in 2017Q3. The ratio is positive, as 77 investment professionals increased and started new positions, while 56 sold and decreased their positions in Intrexon Corp. The investment professionals in our partner’s database now own: 96.48 million shares, up from 92.42 million shares in 2017Q3. Also, the number of investment professionals holding Intrexon Corp in their top 10 positions was flat from 2 to 2 for the same number . Sold All: 20 Reduced: 36 Increased: 50 New Position: 27.

Intrexon Corporation operates in the synthetic biology field in the United States. The company has market cap of $2.47 billion. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. It currently has negative earnings. The Company’s technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing; and ActoBiotics platform.

The stock increased 1.48% or $0.28 during the last trading session, reaching $19.14. About 896,834 shares traded. Intrexon Corporation (NYSE:XON) has declined 19.93% since April 17, 2017 and is downtrending. It has underperformed by 31.48% the S&P500.

Analysts await Intrexon Corporation (NYSE:XON) to report earnings on May, 9. They expect $-0.24 earnings per share, up 7.69 % or $0.02 from last year’s $-0.26 per share. After $-0.17 actual earnings per share reported by Intrexon Corporation for the previous quarter, Wall Street now forecasts 41.18 % negative EPS growth.

Third Security Llc holds 57.24% of its portfolio in Intrexon Corporation for 57.93 million shares. Michael & Susan Dell Foundation owns 432,878 shares or 3.32% of their US portfolio. Moreover, First Washington Corp has 1.57% invested in the company for 289,990 shares. The Connecticut-based Oracle Investment Management Inc has invested 0.45% in the stock. Iridian Asset Management Llc Ct, a Connecticut-based fund reported 4.52 million shares.#img1#

Since January 1, 0001, it had 1 insider purchase, and 0 insider sales for $12.50 million activity.

Intrexon Corporation (NYSE:XON) Ratings Coverage

Ratings analysis reveals 50% of Intrexon Corporation’s analysts are positive. Out of 4 Wall Street analysts rating Intrexon Corporation, 2 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $17.0 while the high is $57. The stock’s average target of $27.75 is 44.98% above today’s ($19.14) share price. XON was included in 6 notes of analysts from November 10, 2017. The firm has “Buy” rating given on Friday, November 10 by Northland Capital. Stifel Nicolaus maintained it with “Buy” rating and $57 target in Friday, November 10 report. Bank of America maintained Intrexon Corporation (NYSE:XON) rating on Friday, November 10. Bank of America has “Neutral” rating and $21 target. The stock of Intrexon Corporation (NYSE:XON) earned “Neutral” rating by Bank of America on Friday, March 2. The stock has “Buy” rating by Northland Capital on Friday, March 2. The stock has “Neutral” rating by JP Morgan on Monday, March 5.

Intrexon Corporation (NYSE:XON) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.